NYSE: MCSMarcus Corp Stock
$15.94+0.35 (+2.25%)
Updated Feb 10, 2026
MCS Price
$15.94
Fair Value Price
N/A
Market Cap
$489.58M
52 Week Low
$12.85
52 Week High
$22.38
P/E
61.31x
P/B
1.08x
P/S
0.65x
PEG
0.82x
Dividend Yield
1.88%
Revenue
$753.27M
Earnings
$7.72M
Gross Margin
38.5%
Operating Margin
2.16%
Profit Margin
1%
Debt to Equity
1.21
Operating Cash Flow
$88M
Beta
0.73
Next Earnings
Feb 26, 2026
Ex-Dividend
N/A
Next Dividend
N/A
MCS Overview
Marcus Corporation operates movie theatres and hotels and resorts in the U.S. It has two business segments. The company also offers hospitality management services. Marcus was founded in 1935 and is headquartered in Milwaukee, WI.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MCS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Entertainment
Industry Rating
F
MCS
Ranked#18 of 37
Ranked#18 of 37
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.13 | A | |
| $36.49 | A | |
| $2.30 | B |
Be the first to know about important MCS news, forecast changes, insider trades & much more!
MCS News
Overview
Due Diligence Score
–
Industry Average (21)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MCS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MCS ($15.94) is trading above its intrinsic value of $8.69, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MCS is poor value based on its earnings relative to its share price (61.31x), compared to the US market average (43.98x)
P/E vs Market Valuation
MCS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MCS due diligence checks available for Premium users.
Valuation
MCS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
61.31x
Industry
10.59x
Market
43.98x
MCS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MCS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MCS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.08x
Industry
3.36x
MCS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MCS price to earnings growth (PEG)
For valuing profitable companies with growth potential
MCS is good value based... subscribe to Premium to read more.
PEG Value Valuation
MCS's financial health
Profit margin
Revenue
$210.2M
Net Income
$16.2M
Profit Margin
7.7%
MCS's Earnings (EBIT) of $16.27M... subscribe to Premium to read more.
Interest Coverage Financials
MCS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.0B
Liabilities
$550.0M
Debt to equity
1.21
MCS's short-term liabilities ($144.21M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MCS's long-term liabilities ($405.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MCS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MCS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$39.1M
Investing
-$15.1M
Financing
-$30.2M
MCS's operating cash flow ($87.97M)... subscribe to Premium to read more.
Debt Coverage Financials
MCS vs Entertainment Stocks
Marcus Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.